Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
A urinalysis is a group of physical, chemical, and microscopic tests to detect and manage a wide range of disorders, such as urinary tract infections, kidney disease and diabetes. A urinalysis involves checking the appearance, concentration and content of urine. The most common use of urinalysis is to detect substances or cells in the urine that point to diagnose disease or to screen for health problems. The urinalysis is conducted as pre-surgery preparation, routine medical check-up, pregnancy check-up, or on hospital admission to treat innumerable disorders such as kidney disorders, urinary tract infections, liver problems, diabetes or other metabolic conditions, to name a few.
The Urinalysis Market is majorly driven by the increasing incidence of target diseases such as diabetes, kidney disorders, urinary tract infections coupled with the rise in geriatric population. Furthermore, the growing prevalence of sedentary lifestyle in individuals fuels the epidemic in many regions. According to Centers for Disease Control and Prevention (CDC), diabetes is one of the most common chronic diseases among humans, around 30.3 million people or 9.4% of the U.S population suffers from diabetes. In 2015, an estimated 1.5 million new cases of diabetes were diagnosed among people ages 18 and older. In addition, increasing healthcare expenditure and rising adoption of point-of-care urinalysis devices is likely to boost the growth of the market. Conversely, high costs of R&D, implementation of excise tax by the U.S. government and stringent regulatory procedures are major factors that hinder the growth of the market. Further, development of portable and battery-operated urinalysis devices and unmet clinical needs in the emerging economic countries including China, India and others, will create new opportunities for the urinalysis market.
The report analyses the Urinalysis Market based on Product, Test, Application, End User and Geography.
Based on product and service, the market is bifurcated two segments namely instruments, and consumables. The instrument segment is comprising of Biochemical Urine Analyzers, Automated Urine Sediment Analyzers and Point-Of-Care Devices. Biochemical Urine Analyzers segment is further categorised into Automated Biochemical Urine Analyzers and Semi-Automated Biochemical Urine Analyzers. Also, the consumable segment is sub categorises into Dipsticks, Reagents and Disposables. The consumables segment is expected to account for the largest share of the global market attributed to the wide use of disposables in urinalysis testing and research coupled with the introduction of new and advanced reagents & dipsticks. Further, instrument segment is anticipated to observe lucrative growth over the forecast period attributed to the factors such as technological advancements in the instruments such as fully automated urine strip readers and automated urine sediment analysers are estimated to accentuate the growth of this.
By test type the market is classified into biochemical urinalysis and sediment test type. The biochemical urinalysis segment is observing the lucrative market growth over the forecast period owing to the factors including technological advancement and new product launch in the biochemical urinalysis segment. For example, the diagnostics division of Siemens Healthcare launched CLINITEK Novus Automated Urine Chemistry Analyzer which is a advanced urine testing solutions. Introduction of new and advanced biochemical urine analyser is likely to augment the segmental growth of the market.
The Urinalysis Market finds application in disease diagnostics and pregnancy tests. The diseases diagnostics segment is sub-segmented into Urinary Tract Infections (UTIS), Kidney Diseases, Diabetes, Liver Diseases and others. The disease diagnosis application segment is projected to witness the lucrative growth during the forecast period. The propelling factors for the growth the diagnostic disease segment includes increasing research for the development of new urinalysis tests for better, early diagnosis of chronic diseases coupled with the growing incidences of chronic diseases. As per World Health Organisation, the chronic disease is expected to account for almost three-quarters of all deaths worldwide by 2020. Further, the number of people in the developing world with diabetes are expected to increase by more than 2.5-fold, from 84 million in 1995 to 228 million in 2025. As urinalysis plays an important role in the diagnosis of such diseases, the urinalysis market is anticipated to grow significantly in the near future.
On the basis of end user, the market is categorized into Hospitals & Clinics, Diagnostic Laboratories, Research Laboratories and Institutes and Home Care Settings. Home care setting is anticipated to robust growth during the forecast period owing to the increasing trend of automation being used in the urine analysis diagnostics is anticipated to provide an ancillary force for the growth of point-of-care and self-testing-based urinalysis.
Geographically, the global Urinalysis Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (ROW).
North America accounted for the largest share of the Urinalysis Market in 2018 followed by Europe and Asia Pacific. The dominance of the North America region is attributed to the increasing prevalence of kidney diseases and urinary tract infections, generous investments and funding available for research in this field existing well-established healthcare system, presence of key market players in the region, presence of key market players in the region. Further in USA, the diabetes prevalence is also on the rise which will contribute to the regional growth of the market. As per, American Diabetes Association, 30.3 million Americans or 9.4% of the population, had diabetes. Adults with diabetes, high blood pressure, or both have a higher risk of developing kidney diseases. Which in turn, highlights the rising need of urinalysis in this region.
Moreover, Asia-Pacific region is observing robust growth in the market owing to the capability, increasing penetration rate of advanced urine analyzers, increasing investments by pharmaceutical companies, presence of large patient pool and developing healthcare infrastructure will further augment region growth.
Some of the major players operating in this market are Arkray Inc., Beckman Coulter Inc., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Elektronika KFT., Acon Laboratories Inc., Bio-Rad Laboratories Inc., Mindray Medical International Limited, and URIT Medical Electronic Group Co. Ltd among others.
The report analyses the Urinalysis Market based on Product, Test, Application, End User and Geography.Based on product and service, the market is bifurcated two segments namely instruments, and consumables. The instrument segment is comprising of Biochemical Urine Analyzers, Automated Urine Sediment Analyzers and Point-Of-Care Devices. Biochemical Urine Analyzers segment is further categorised into Automated Biochemical Urine Analyzers and Semi-Automated Biochemical Urine Analyzers. Also, the consumable segment is sub categorises into Dipsticks, Reagents and Disposables. By test type the market is classified into biochemical urinalysis and sediment test type. The Urinalysis Market finds application in disease diagnostics and pregnancy tests. The diseases diagnostics segment is sub-segmented into Urinary Tract Infections (UTIS), Kidney Diseases, Diabetes, Liver Diseases and others.
On the basis of end user, the market is categorized into Hospitals & Clinics, Diagnostic Laboratories, Research Laboratories and Institutes and Home Care Settings. Geographically, the global Urinalysis Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (ROW).
Some of the major players operating in this market are Arkray Inc., Beckman Coulter Inc., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Elektronika KFT., Acon Laboratories Inc., Bio-Rad Laboratories Inc., Mindray Medical International Limited, and URIT Medical Electronic Group Co. Ltd among others.
Why to buy this report:
